Summary

The global Burns and Scalds Treatment market size is predicted to grow from US$ 2443 million in 2025 to US$ 3192 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.
In 2025, the global production volume of Burns and Scalds Treatment products reached approximately 135 million units, with an average selling price of USD 18.5 per unit, production capacity of approximately 185 million units, and a gross margin of 42%.
Burns and Scalds Treatment refers to therapeutic products and related wound-care products used for skin and soft-tissue thermal injuries caused by flames, hot liquids, steam, contact with hot objects, and other heat sources. Major products include burn ointments and creams, gels, sprays, and burn wound dressings. These products are primarily used to protect wounds, maintain an appropriate wound-healing environment, relieve local discomfort, and support wound repair. Depending on the depth and severity of the burn, they are used across home first aid, outpatient clinics, hospitals, and specialized burn care settings.
The Burns and Scalds Treatment market is mainly driven by demand arising from household accidents, industrial accidents, kitchen and food-service scalds, fires, and other thermal injuries. The product mix is gradually expanding from traditional burn ointments, creams, and basic dressings toward advanced wound-care products such as hydrogels, foam dressings, and antimicrobial dressings. Hospitals place greater emphasis on infection control, wound-healing performance, and ease of dressing changes, while the home-care market focuses more on convenience and immediate first-aid treatment. With continued advances in wound-care technologies and improved burn wound management in healthcare institutions, the penetration of higher-value advanced dressings and professional burn-care products is expected to increase further.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Burns and Scalds Treatment Industry Forecast” looks at past sales and reviews total world Burns and Scalds Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Burns and Scalds Treatment sales for 2026 through 2032. With Burns and Scalds Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Burns and Scalds Treatment industry.
This Insight Report provides a comprehensive analysis of the global Burns and Scalds Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Burns and Scalds Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Burns and Scalds Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Burns and Scalds Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Burns and Scalds Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Burns and Scalds Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
Salve
Spray
Oil
Other
Segmentation by Treatment Product Type:
Burn Ointments and Creams
Burn Dressings
Burn Sprays and Gels
Others
Segmentation by Burn Depth:
Superficial Burns (First-degree)
Superficial Partial-thickness Burns (Superficial Second-degree)
Deep Partial-thickness Burns (Deep Second-degree)
Full-thickness Burns (Third-degree)
Segmentation by Application:
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MEBO
B. Braun
Integra LifeSciences
Tianjin Pharmaceutical Da Ren Tang Group Corporation
Smith & Nephew
Yangtze River Pharmaceutical
STADA Thornton & Ross
Kenvue Brands LLC
Changchun OVERSEAS
Orkla Health
Guangdong Hengjian Investment
Otsuka Pharmaceutical Co
Tonghua Maoxiang Medical Co
Cipla
Mitsubishi Tanabe Pharma Corporation
Chongqing GankyilL Bio-Technology
Quest Products, LLC
Jianmin Pharmaceutical Group Co
Acme United Corp.
Dongwha Pharm
CR Pharmaceutical Commercial Group Co
Safetec Of America
Chongqing Taiji Industry
North China Pharmaceutical Co
Xiangxi Hongcheng
Aoxing Pharmaceutical
Jilin Aodong Pharmaceutical Group Co
Beijing Tong Ren Tang Chinese Medicine Co
Key Questions Addressed in this Report
What is the 10-year outlook for the global Burns and Scalds Treatment market?
What factors are driving Burns and Scalds Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Burns and Scalds Treatment market opportunities vary by end market size?
How does Burns and Scalds Treatment break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Burns and Scalds Treatment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Burns and Scalds Treatment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Burns and Scalds Treatment by Country/Region, 2021, 2025 & 2032
2.2 Burns and Scalds Treatment Segment by Type
2.2.1 Salve
2.2.2 Spray
2.2.3 Oil
2.2.4 Other
2.2.5 Burns and Scalds Treatment Sales by Type
2.2.5.1 Global Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
2.2.5.2 Global Burns and Scalds Treatment Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Burns and Scalds Treatment Sale Price by Type (2021-2026)
2.3 Burns and Scalds Treatment Segment by Treatment Product Type
2.3.1 Burn Ointments and Creams
2.3.2 Burn Dressings
2.3.3 Burn Sprays and Gels
2.3.4 Others
2.3.5 Burns and Scalds Treatment Sales by Treatment Product Type
2.3.5.1 Global Burns and Scalds Treatment Sales Market Share by Treatment Product Type (2021-2026)
2.3.5.2 Global Burns and Scalds Treatment Revenue and Market Share by Treatment Product Type (2021-2026)
2.3.5.3 Global Burns and Scalds Treatment Sale Price by Treatment Product Type (2021-2026)
2.4 Burns and Scalds Treatment Segment by Burn Depth
2.4.1 Superficial Burns (First-degree)
2.4.2 Superficial Partial-thickness Burns (Superficial Second-degree)
2.4.3 Deep Partial-thickness Burns (Deep Second-degree)
2.4.4 Full-thickness Burns (Third-degree)
2.4.5 Burns and Scalds Treatment Sales by Burn Depth
2.4.5.1 Global Burns and Scalds Treatment Sales Market Share by Burn Depth (2021-2026)
2.4.5.2 Global Burns and Scalds Treatment Revenue and Market Share by Burn Depth (2021-2026)
2.4.5.3 Global Burns and Scalds Treatment Sale Price by Burn Depth (2021-2026)
2.5 Burns and Scalds Treatment Segment by Application
2.5.1 Hospitals and Clinics
2.5.2 Retail Pharmacies
2.5.3 E-commerce Platforms
2.5.4 Other
2.5.5 Burns and Scalds Treatment Sales by Application
2.5.5.1 Global Burns and Scalds Treatment Sale Market Share by Application (2021-2026)
2.5.5.2 Global Burns and Scalds Treatment Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Burns and Scalds Treatment Sale Price by Application (2021-2026)

3 Global by Company
3.1 Global Burns and Scalds Treatment Breakdown Data by Company
3.1.1 Global Burns and Scalds Treatment Annual Sales by Company (2021-2026)
3.1.2 Global Burns and Scalds Treatment Sales Market Share by Company (2021-2026)
3.2 Global Burns and Scalds Treatment Annual Revenue by Company (2021-2026)
3.2.1 Global Burns and Scalds Treatment Revenue by Company (2021-2026)
3.2.2 Global Burns and Scalds Treatment Revenue Market Share by Company (2021-2026)
3.3 Global Burns and Scalds Treatment Sale Price by Company
3.4 Key Manufacturers Burns and Scalds Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Burns and Scalds Treatment Product Location Distribution
3.4.2 Players Burns and Scalds Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 World Historic Review for Burns and Scalds Treatment by Geographic Region
4.1 World Historic Burns and Scalds Treatment Market Size by Geographic Region (2021-2026)
4.1.1 Global Burns and Scalds Treatment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Burns and Scalds Treatment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Burns and Scalds Treatment Market Size by Country/Region (2021-2026)
4.2.1 Global Burns and Scalds Treatment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Burns and Scalds Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Burns and Scalds Treatment Sales Growth
4.4 APAC Burns and Scalds Treatment Sales Growth
4.5 Europe Burns and Scalds Treatment Sales Growth
4.6 Middle East & Africa Burns and Scalds Treatment Sales Growth

5 Americas
5.1 Americas Burns and Scalds Treatment Sales by Country
5.1.1 Americas Burns and Scalds Treatment Sales by Country (2021-2026)
5.1.2 Americas Burns and Scalds Treatment Revenue by Country (2021-2026)
5.2 Americas Burns and Scalds Treatment Sales by Type (2021-2026)
5.3 Americas Burns and Scalds Treatment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Burns and Scalds Treatment Sales by Region
6.1.1 APAC Burns and Scalds Treatment Sales by Region (2021-2026)
6.1.2 APAC Burns and Scalds Treatment Revenue by Region (2021-2026)
6.2 APAC Burns and Scalds Treatment Sales by Type (2021-2026)
6.3 APAC Burns and Scalds Treatment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 Europe
7.1 Europe Burns and Scalds Treatment by Country
7.1.1 Europe Burns and Scalds Treatment Sales by Country (2021-2026)
7.1.2 Europe Burns and Scalds Treatment Revenue by Country (2021-2026)
7.2 Europe Burns and Scalds Treatment Sales by Type (2021-2026)
7.3 Europe Burns and Scalds Treatment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Burns and Scalds Treatment by Country
8.1.1 Middle East & Africa Burns and Scalds Treatment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Burns and Scalds Treatment Revenue by Country (2021-2026)
8.2 Middle East & Africa Burns and Scalds Treatment Sales by Type (2021-2026)
8.3 Middle East & Africa Burns and Scalds Treatment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Burns and Scalds Treatment
10.3 Manufacturing Process Analysis of Burns and Scalds Treatment
10.4 Industry Chain Structure of Burns and Scalds Treatment

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Burns and Scalds Treatment Distributors
11.3 Burns and Scalds Treatment Customer

12 World Forecast Review for Burns and Scalds Treatment by Geographic Region
12.1 Global Burns and Scalds Treatment Market Size Forecast by Region
12.1.1 Global Burns and Scalds Treatment Forecast by Region (2027-2032)
12.1.2 Global Burns and Scalds Treatment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Burns and Scalds Treatment Forecast by Type (2027-2032)
12.7 Global Burns and Scalds Treatment Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 MEBO
13.1.1 MEBO Company Information
13.1.2 MEBO Burns and Scalds Treatment Product Portfolios and Specifications
13.1.3 MEBO Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MEBO Main Business Overview
13.1.5 MEBO Latest Developments
13.2 B. Braun
13.2.1 B. Braun Company Information
13.2.2 B. Braun Burns and Scalds Treatment Product Portfolios and Specifications
13.2.3 B. Braun Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 B. Braun Main Business Overview
13.2.5 B. Braun Latest Developments
13.3 Integra LifeSciences
13.3.1 Integra LifeSciences Company Information
13.3.2 Integra LifeSciences Burns and Scalds Treatment Product Portfolios and Specifications
13.3.3 Integra LifeSciences Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Integra LifeSciences Main Business Overview
13.3.5 Integra LifeSciences Latest Developments
13.4 Tianjin Pharmaceutical Da Ren Tang Group Corporation
13.4.1 Tianjin Pharmaceutical Da Ren Tang Group Corporation Company Information
13.4.2 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Product Portfolios and Specifications
13.4.3 Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Tianjin Pharmaceutical Da Ren Tang Group Corporation Main Business Overview
13.4.5 Tianjin Pharmaceutical Da Ren Tang Group Corporation Latest Developments
13.5 Smith & Nephew
13.5.1 Smith & Nephew Company Information
13.5.2 Smith & Nephew Burns and Scalds Treatment Product Portfolios and Specifications
13.5.3 Smith & Nephew Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Smith & Nephew Main Business Overview
13.5.5 Smith & Nephew Latest Developments
13.6 Yangtze River Pharmaceutical
13.6.1 Yangtze River Pharmaceutical Company Information
13.6.2 Yangtze River Pharmaceutical Burns and Scalds Treatment Product Portfolios and Specifications
13.6.3 Yangtze River Pharmaceutical Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Yangtze River Pharmaceutical Main Business Overview
13.6.5 Yangtze River Pharmaceutical Latest Developments
13.7 STADA Thornton & Ross
13.7.1 STADA Thornton & Ross Company Information
13.7.2 STADA Thornton & Ross Burns and Scalds Treatment Product Portfolios and Specifications
13.7.3 STADA Thornton & Ross Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 STADA Thornton & Ross Main Business Overview
13.7.5 STADA Thornton & Ross Latest Developments
13.8 Kenvue Brands LLC
13.8.1 Kenvue Brands LLC Company Information
13.8.2 Kenvue Brands LLC Burns and Scalds Treatment Product Portfolios and Specifications
13.8.3 Kenvue Brands LLC Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kenvue Brands LLC Main Business Overview
13.8.5 Kenvue Brands LLC Latest Developments
13.9 Changchun OVERSEAS
13.9.1 Changchun OVERSEAS Company Information
13.9.2 Changchun OVERSEAS Burns and Scalds Treatment Product Portfolios and Specifications
13.9.3 Changchun OVERSEAS Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Changchun OVERSEAS Main Business Overview
13.9.5 Changchun OVERSEAS Latest Developments
13.10 Orkla Health
13.10.1 Orkla Health Company Information
13.10.2 Orkla Health Burns and Scalds Treatment Product Portfolios and Specifications
13.10.3 Orkla Health Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Orkla Health Main Business Overview
13.10.5 Orkla Health Latest Developments
13.11 Guangdong Hengjian Investment
13.11.1 Guangdong Hengjian Investment Company Information
13.11.2 Guangdong Hengjian Investment Burns and Scalds Treatment Product Portfolios and Specifications
13.11.3 Guangdong Hengjian Investment Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Hengjian Investment Main Business Overview
13.11.5 Guangdong Hengjian Investment Latest Developments
13.12 Otsuka Pharmaceutical Co
13.12.1 Otsuka Pharmaceutical Co Company Information
13.12.2 Otsuka Pharmaceutical Co Burns and Scalds Treatment Product Portfolios and Specifications
13.12.3 Otsuka Pharmaceutical Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Otsuka Pharmaceutical Co Main Business Overview
13.12.5 Otsuka Pharmaceutical Co Latest Developments
13.13 Tonghua Maoxiang Medical Co
13.13.1 Tonghua Maoxiang Medical Co Company Information
13.13.2 Tonghua Maoxiang Medical Co Burns and Scalds Treatment Product Portfolios and Specifications
13.13.3 Tonghua Maoxiang Medical Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Tonghua Maoxiang Medical Co Main Business Overview
13.13.5 Tonghua Maoxiang Medical Co Latest Developments
13.14 Cipla
13.14.1 Cipla Company Information
13.14.2 Cipla Burns and Scalds Treatment Product Portfolios and Specifications
13.14.3 Cipla Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Cipla Main Business Overview
13.14.5 Cipla Latest Developments
13.15 Mitsubishi Tanabe Pharma Corporation
13.15.1 Mitsubishi Tanabe Pharma Corporation Company Information
13.15.2 Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Product Portfolios and Specifications
13.15.3 Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
13.15.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
13.16 Chongqing GankyilL Bio-Technology
13.16.1 Chongqing GankyilL Bio-Technology Company Information
13.16.2 Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Product Portfolios and Specifications
13.16.3 Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Chongqing GankyilL Bio-Technology Main Business Overview
13.16.5 Chongqing GankyilL Bio-Technology Latest Developments
13.17 Quest Products, LLC
13.17.1 Quest Products, LLC Company Information
13.17.2 Quest Products, LLC Burns and Scalds Treatment Product Portfolios and Specifications
13.17.3 Quest Products, LLC Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Quest Products, LLC Main Business Overview
13.17.5 Quest Products, LLC Latest Developments
13.18 Jianmin Pharmaceutical Group Co
13.18.1 Jianmin Pharmaceutical Group Co Company Information
13.18.2 Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Product Portfolios and Specifications
13.18.3 Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jianmin Pharmaceutical Group Co Main Business Overview
13.18.5 Jianmin Pharmaceutical Group Co Latest Developments
13.19 Acme United Corp.
13.19.1 Acme United Corp. Company Information
13.19.2 Acme United Corp. Burns and Scalds Treatment Product Portfolios and Specifications
13.19.3 Acme United Corp. Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Acme United Corp. Main Business Overview
13.19.5 Acme United Corp. Latest Developments
13.20 Dongwha Pharm
13.20.1 Dongwha Pharm Company Information
13.20.2 Dongwha Pharm Burns and Scalds Treatment Product Portfolios and Specifications
13.20.3 Dongwha Pharm Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Dongwha Pharm Main Business Overview
13.20.5 Dongwha Pharm Latest Developments
13.21 CR Pharmaceutical Commercial Group Co
13.21.1 CR Pharmaceutical Commercial Group Co Company Information
13.21.2 CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Product Portfolios and Specifications
13.21.3 CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 CR Pharmaceutical Commercial Group Co Main Business Overview
13.21.5 CR Pharmaceutical Commercial Group Co Latest Developments
13.22 Safetec Of America
13.22.1 Safetec Of America Company Information
13.22.2 Safetec Of America Burns and Scalds Treatment Product Portfolios and Specifications
13.22.3 Safetec Of America Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Safetec Of America Main Business Overview
13.22.5 Safetec Of America Latest Developments
13.23 Chongqing Taiji Industry
13.23.1 Chongqing Taiji Industry Company Information
13.23.2 Chongqing Taiji Industry Burns and Scalds Treatment Product Portfolios and Specifications
13.23.3 Chongqing Taiji Industry Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Chongqing Taiji Industry Main Business Overview
13.23.5 Chongqing Taiji Industry Latest Developments
13.24 North China Pharmaceutical Co
13.24.1 North China Pharmaceutical Co Company Information
13.24.2 North China Pharmaceutical Co Burns and Scalds Treatment Product Portfolios and Specifications
13.24.3 North China Pharmaceutical Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 North China Pharmaceutical Co Main Business Overview
13.24.5 North China Pharmaceutical Co Latest Developments
13.25 Xiangxi Hongcheng
13.25.1 Xiangxi Hongcheng Company Information
13.25.2 Xiangxi Hongcheng Burns and Scalds Treatment Product Portfolios and Specifications
13.25.3 Xiangxi Hongcheng Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Xiangxi Hongcheng Main Business Overview
13.25.5 Xiangxi Hongcheng Latest Developments
13.26 Aoxing Pharmaceutical
13.26.1 Aoxing Pharmaceutical Company Information
13.26.2 Aoxing Pharmaceutical Burns and Scalds Treatment Product Portfolios and Specifications
13.26.3 Aoxing Pharmaceutical Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Aoxing Pharmaceutical Main Business Overview
13.26.5 Aoxing Pharmaceutical Latest Developments
13.27 Jilin Aodong Pharmaceutical Group Co
13.27.1 Jilin Aodong Pharmaceutical Group Co Company Information
13.27.2 Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Product Portfolios and Specifications
13.27.3 Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Jilin Aodong Pharmaceutical Group Co Main Business Overview
13.27.5 Jilin Aodong Pharmaceutical Group Co Latest Developments
13.28 Beijing Tong Ren Tang Chinese Medicine Co
13.28.1 Beijing Tong Ren Tang Chinese Medicine Co Company Information
13.28.2 Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Product Portfolios and Specifications
13.28.3 Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Beijing Tong Ren Tang Chinese Medicine Co Main Business Overview
13.28.5 Beijing Tong Ren Tang Chinese Medicine Co Latest Developments

14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Burns and Scalds Treatment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Burns and Scalds Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Salve
Table 4. Major Players of Spray
Table 5. Major Players of Oil
Table 6. Major Players of Other
Table 7. Global Burns and Scalds Treatment Sales by Type (2021-2026) & (K Units)
Table 8. Global Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
Table 9. Global Burns and Scalds Treatment Revenue by Type (2021-2026) & ($ million)
Table 10. Global Burns and Scalds Treatment Revenue Market Share by Type (2021-2026)
Table 11. Global Burns and Scalds Treatment Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Burn Ointments and Creams
Table 13. Major Players of Burn Dressings
Table 14. Major Players of Burn Sprays and Gels
Table 15. Major Players of Others
Table 16. Global Burns and Scalds Treatment Sales by Treatment Product Type (2021-2026) & (K Units)
Table 17. Global Burns and Scalds Treatment Sales Market Share by Treatment Product Type (2021-2026)
Table 18. Global Burns and Scalds Treatment Revenue by Treatment Product Type (2021-2026) & ($ million)
Table 19. Global Burns and Scalds Treatment Revenue Market Share by Treatment Product Type (2021-2026)
Table 20. Global Burns and Scalds Treatment Sale Price by Treatment Product Type (2021-2026) & (US$/Unit)
Table 21. Major Players of Superficial Burns (First-degree)
Table 22. Major Players of Superficial Partial-thickness Burns (Superficial Second-degree)
Table 23. Major Players of Deep Partial-thickness Burns (Deep Second-degree)
Table 24. Major Players of Full-thickness Burns (Third-degree)
Table 25. Global Burns and Scalds Treatment Sales by Burn Depth (2021-2026) & (K Units)
Table 26. Global Burns and Scalds Treatment Sales Market Share by Burn Depth (2021-2026)
Table 27. Global Burns and Scalds Treatment Revenue by Burn Depth (2021-2026) & ($ million)
Table 28. Global Burns and Scalds Treatment Revenue Market Share by Burn Depth (2021-2026)
Table 29. Global Burns and Scalds Treatment Sale Price by Burn Depth (2021-2026) & (US$/Unit)
Table 30. Global Burns and Scalds Treatment Sale by Application (2021-2026) & (K Units)
Table 31. Global Burns and Scalds Treatment Sale Market Share by Application (2021-2026)
Table 32. Global Burns and Scalds Treatment Revenue by Application (2021-2026) & ($ million)
Table 33. Global Burns and Scalds Treatment Revenue Market Share by Application (2021-2026)
Table 34. Global Burns and Scalds Treatment Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Burns and Scalds Treatment Sales by Company (2021-2026) & (K Units)
Table 36. Global Burns and Scalds Treatment Sales Market Share by Company (2021-2026)
Table 37. Global Burns and Scalds Treatment Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Burns and Scalds Treatment Revenue Market Share by Company (2021-2026)
Table 39. Global Burns and Scalds Treatment Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Burns and Scalds Treatment Producing Area Distribution and Sales Area
Table 41. Players Burns and Scalds Treatment Products Offered
Table 42. Burns and Scalds Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Burns and Scalds Treatment Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Burns and Scalds Treatment Sales Market Share Geographic Region (2021-2026)
Table 47. Global Burns and Scalds Treatment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Burns and Scalds Treatment Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Burns and Scalds Treatment Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Burns and Scalds Treatment Sales Market Share by Country/Region (2021-2026)
Table 51. Global Burns and Scalds Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Burns and Scalds Treatment Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Burns and Scalds Treatment Sales by Country (2021-2026) & (K Units)
Table 54. Americas Burns and Scalds Treatment Sales Market Share by Country (2021-2026)
Table 55. Americas Burns and Scalds Treatment Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Burns and Scalds Treatment Sales by Type (2021-2026) & (K Units)
Table 57. Americas Burns and Scalds Treatment Sales by Application (2021-2026) & (K Units)
Table 58. APAC Burns and Scalds Treatment Sales by Region (2021-2026) & (K Units)
Table 59. APAC Burns and Scalds Treatment Sales Market Share by Region (2021-2026)
Table 60. APAC Burns and Scalds Treatment Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Burns and Scalds Treatment Sales by Type (2021-2026) & (K Units)
Table 62. APAC Burns and Scalds Treatment Sales by Application (2021-2026) & (K Units)
Table 63. Europe Burns and Scalds Treatment Sales by Country (2021-2026) & (K Units)
Table 64. Europe Burns and Scalds Treatment Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Burns and Scalds Treatment Sales by Type (2021-2026) & (K Units)
Table 66. Europe Burns and Scalds Treatment Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Burns and Scalds Treatment Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Burns and Scalds Treatment Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Burns and Scalds Treatment Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Burns and Scalds Treatment Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Burns and Scalds Treatment
Table 72. Key Market Challenges & Risks of Burns and Scalds Treatment
Table 73. Key Industry Trends of Burns and Scalds Treatment
Table 74. Burns and Scalds Treatment Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Burns and Scalds Treatment Distributors List
Table 77. Burns and Scalds Treatment Customer List
Table 78. Global Burns and Scalds Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Burns and Scalds Treatment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Burns and Scalds Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Burns and Scalds Treatment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Burns and Scalds Treatment Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Burns and Scalds Treatment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Burns and Scalds Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Burns and Scalds Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Burns and Scalds Treatment Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Burns and Scalds Treatment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Burns and Scalds Treatment Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Burns and Scalds Treatment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Burns and Scalds Treatment Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Burns and Scalds Treatment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. MEBO Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. MEBO Burns and Scalds Treatment Product Portfolios and Specifications
Table 94. MEBO Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. MEBO Main Business
Table 96. MEBO Latest Developments
Table 97. B. Braun Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. B. Braun Burns and Scalds Treatment Product Portfolios and Specifications
Table 99. B. Braun Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. B. Braun Main Business
Table 101. B. Braun Latest Developments
Table 102. Integra LifeSciences Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Integra LifeSciences Burns and Scalds Treatment Product Portfolios and Specifications
Table 104. Integra LifeSciences Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Integra LifeSciences Main Business
Table 106. Integra LifeSciences Latest Developments
Table 107. Tianjin Pharmaceutical Da Ren Tang Group Corporation Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Product Portfolios and Specifications
Table 109. Tianjin Pharmaceutical Da Ren Tang Group Corporation Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Tianjin Pharmaceutical Da Ren Tang Group Corporation Main Business
Table 111. Tianjin Pharmaceutical Da Ren Tang Group Corporation Latest Developments
Table 112. Smith & Nephew Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. Smith & Nephew Burns and Scalds Treatment Product Portfolios and Specifications
Table 114. Smith & Nephew Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Smith & Nephew Main Business
Table 116. Smith & Nephew Latest Developments
Table 117. Yangtze River Pharmaceutical Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Yangtze River Pharmaceutical Burns and Scalds Treatment Product Portfolios and Specifications
Table 119. Yangtze River Pharmaceutical Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Yangtze River Pharmaceutical Main Business
Table 121. Yangtze River Pharmaceutical Latest Developments
Table 122. STADA Thornton & Ross Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. STADA Thornton & Ross Burns and Scalds Treatment Product Portfolios and Specifications
Table 124. STADA Thornton & Ross Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. STADA Thornton & Ross Main Business
Table 126. STADA Thornton & Ross Latest Developments
Table 127. Kenvue Brands LLC Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 128. Kenvue Brands LLC Burns and Scalds Treatment Product Portfolios and Specifications
Table 129. Kenvue Brands LLC Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Kenvue Brands LLC Main Business
Table 131. Kenvue Brands LLC Latest Developments
Table 132. Changchun OVERSEAS Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 133. Changchun OVERSEAS Burns and Scalds Treatment Product Portfolios and Specifications
Table 134. Changchun OVERSEAS Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Changchun OVERSEAS Main Business
Table 136. Changchun OVERSEAS Latest Developments
Table 137. Orkla Health Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 138. Orkla Health Burns and Scalds Treatment Product Portfolios and Specifications
Table 139. Orkla Health Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Orkla Health Main Business
Table 141. Orkla Health Latest Developments
Table 142. Guangdong Hengjian Investment Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 143. Guangdong Hengjian Investment Burns and Scalds Treatment Product Portfolios and Specifications
Table 144. Guangdong Hengjian Investment Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Guangdong Hengjian Investment Main Business
Table 146. Guangdong Hengjian Investment Latest Developments
Table 147. Otsuka Pharmaceutical Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 148. Otsuka Pharmaceutical Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 149. Otsuka Pharmaceutical Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Otsuka Pharmaceutical Co Main Business
Table 151. Otsuka Pharmaceutical Co Latest Developments
Table 152. Tonghua Maoxiang Medical Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 153. Tonghua Maoxiang Medical Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 154. Tonghua Maoxiang Medical Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Tonghua Maoxiang Medical Co Main Business
Table 156. Tonghua Maoxiang Medical Co Latest Developments
Table 157. Cipla Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 158. Cipla Burns and Scalds Treatment Product Portfolios and Specifications
Table 159. Cipla Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Cipla Main Business
Table 161. Cipla Latest Developments
Table 162. Mitsubishi Tanabe Pharma Corporation Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 163. Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Product Portfolios and Specifications
Table 164. Mitsubishi Tanabe Pharma Corporation Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Mitsubishi Tanabe Pharma Corporation Main Business
Table 166. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 167. Chongqing GankyilL Bio-Technology Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 168. Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Product Portfolios and Specifications
Table 169. Chongqing GankyilL Bio-Technology Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Chongqing GankyilL Bio-Technology Main Business
Table 171. Chongqing GankyilL Bio-Technology Latest Developments
Table 172. Quest Products, LLC Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 173. Quest Products, LLC Burns and Scalds Treatment Product Portfolios and Specifications
Table 174. Quest Products, LLC Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Quest Products, LLC Main Business
Table 176. Quest Products, LLC Latest Developments
Table 177. Jianmin Pharmaceutical Group Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 178. Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 179. Jianmin Pharmaceutical Group Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Jianmin Pharmaceutical Group Co Main Business
Table 181. Jianmin Pharmaceutical Group Co Latest Developments
Table 182. Acme United Corp. Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 183. Acme United Corp. Burns and Scalds Treatment Product Portfolios and Specifications
Table 184. Acme United Corp. Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Acme United Corp. Main Business
Table 186. Acme United Corp. Latest Developments
Table 187. Dongwha Pharm Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 188. Dongwha Pharm Burns and Scalds Treatment Product Portfolios and Specifications
Table 189. Dongwha Pharm Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Dongwha Pharm Main Business
Table 191. Dongwha Pharm Latest Developments
Table 192. CR Pharmaceutical Commercial Group Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 193. CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 194. CR Pharmaceutical Commercial Group Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 195. CR Pharmaceutical Commercial Group Co Main Business
Table 196. CR Pharmaceutical Commercial Group Co Latest Developments
Table 197. Safetec Of America Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 198. Safetec Of America Burns and Scalds Treatment Product Portfolios and Specifications
Table 199. Safetec Of America Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 200. Safetec Of America Main Business
Table 201. Safetec Of America Latest Developments
Table 202. Chongqing Taiji Industry Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 203. Chongqing Taiji Industry Burns and Scalds Treatment Product Portfolios and Specifications
Table 204. Chongqing Taiji Industry Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 205. Chongqing Taiji Industry Main Business
Table 206. Chongqing Taiji Industry Latest Developments
Table 207. North China Pharmaceutical Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 208. North China Pharmaceutical Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 209. North China Pharmaceutical Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 210. North China Pharmaceutical Co Main Business
Table 211. North China Pharmaceutical Co Latest Developments
Table 212. Xiangxi Hongcheng Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 213. Xiangxi Hongcheng Burns and Scalds Treatment Product Portfolios and Specifications
Table 214. Xiangxi Hongcheng Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 215. Xiangxi Hongcheng Main Business
Table 216. Xiangxi Hongcheng Latest Developments
Table 217. Aoxing Pharmaceutical Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 218. Aoxing Pharmaceutical Burns and Scalds Treatment Product Portfolios and Specifications
Table 219. Aoxing Pharmaceutical Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 220. Aoxing Pharmaceutical Main Business
Table 221. Aoxing Pharmaceutical Latest Developments
Table 222. Jilin Aodong Pharmaceutical Group Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 223. Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 224. Jilin Aodong Pharmaceutical Group Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 225. Jilin Aodong Pharmaceutical Group Co Main Business
Table 226. Jilin Aodong Pharmaceutical Group Co Latest Developments
Table 227. Beijing Tong Ren Tang Chinese Medicine Co Basic Information, Burns and Scalds Treatment Manufacturing Base, Sales Area and Its Competitors
Table 228. Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Product Portfolios and Specifications
Table 229. Beijing Tong Ren Tang Chinese Medicine Co Burns and Scalds Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 230. Beijing Tong Ren Tang Chinese Medicine Co Main Business
Table 231. Beijing Tong Ren Tang Chinese Medicine Co Latest Developments

List of Figures
Figure 1. Picture of Burns and Scalds Treatment
Figure 2. Burns and Scalds Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Burns and Scalds Treatment Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Burns and Scalds Treatment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Burns and Scalds Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Burns and Scalds Treatment Sales Market Share by Country/Region (2025)
Figure 10. Burns and Scalds Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Salve
Figure 12. Product Picture of Spray
Figure 13. Product Picture of Oil
Figure 14. Product Picture of Other
Figure 15. Global Burns and Scalds Treatment Sales Market Share by Type in 2026
Figure 16. Global Burns and Scalds Treatment Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Burn Ointments and Creams
Figure 18. Product Picture of Burn Dressings
Figure 19. Product Picture of Burn Sprays and Gels
Figure 20. Product Picture of Others
Figure 21. Global Burns and Scalds Treatment Sales Market Share by Treatment Product Type in 2026
Figure 22. Global Burns and Scalds Treatment Revenue Market Share by Treatment Product Type (2021-2026)
Figure 23. Product Picture of Superficial Burns (First-degree)
Figure 24. Product Picture of Superficial Partial-thickness Burns (Superficial Second-degree)
Figure 25. Product Picture of Deep Partial-thickness Burns (Deep Second-degree)
Figure 26. Product Picture of Full-thickness Burns (Third-degree)
Figure 27. Global Burns and Scalds Treatment Sales Market Share by Burn Depth in 2026
Figure 28. Global Burns and Scalds Treatment Revenue Market Share by Burn Depth (2021-2026)
Figure 29. Burns and Scalds Treatment Consumed in Hospitals and Clinics
Figure 30. Global Burns and Scalds Treatment Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 31. Burns and Scalds Treatment Consumed in Retail Pharmacies
Figure 32. Global Burns and Scalds Treatment Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 33. Burns and Scalds Treatment Consumed in E-commerce Platforms
Figure 34. Global Burns and Scalds Treatment Market: E-commerce Platforms (2021-2026) & (K Units)
Figure 35. Burns and Scalds Treatment Consumed in Other
Figure 36. Global Burns and Scalds Treatment Market: Other (2021-2026) & (K Units)
Figure 37. Global Burns and Scalds Treatment Sale Market Share by Application (2025)
Figure 38. Global Burns and Scalds Treatment Revenue Market Share by Application in 2025
Figure 39. Burns and Scalds Treatment Sales by Company in 2025 (K Units)
Figure 40. Global Burns and Scalds Treatment Sales Market Share by Company in 2025
Figure 41. Burns and Scalds Treatment Revenue by Company in 2025 ($ millions)
Figure 42. Global Burns and Scalds Treatment Revenue Market Share by Company in 2025
Figure 43. Global Burns and Scalds Treatment Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Burns and Scalds Treatment Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Burns and Scalds Treatment Sales 2021-2026 (K Units)
Figure 46. Americas Burns and Scalds Treatment Revenue 2021-2026 ($ millions)
Figure 47. APAC Burns and Scalds Treatment Sales 2021-2026 (K Units)
Figure 48. APAC Burns and Scalds Treatment Revenue 2021-2026 ($ millions)
Figure 49. Europe Burns and Scalds Treatment Sales 2021-2026 (K Units)
Figure 50. Europe Burns and Scalds Treatment Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Burns and Scalds Treatment Sales 2021-2026 (K Units)
Figure 52. Middle East & Africa Burns and Scalds Treatment Revenue 2021-2026 ($ millions)
Figure 53. Americas Burns and Scalds Treatment Sales Market Share by Country in 2025
Figure 54. Americas Burns and Scalds Treatment Revenue Market Share by Country (2021-2026)
Figure 55. Americas Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
Figure 56. Americas Burns and Scalds Treatment Sales Market Share by Application (2021-2026)
Figure 57. United States Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Burns and Scalds Treatment Sales Market Share by Region in 2025
Figure 62. APAC Burns and Scalds Treatment Revenue Market Share by Region (2021-2026)
Figure 63. APAC Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
Figure 64. APAC Burns and Scalds Treatment Sales Market Share by Application (2021-2026)
Figure 65. China Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 69. India Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Burns and Scalds Treatment Sales Market Share by Country in 2025
Figure 73. Europe Burns and Scalds Treatment Revenue Market Share by Country (2021-2026)
Figure 74. Europe Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
Figure 75. Europe Burns and Scalds Treatment Sales Market Share by Application (2021-2026)
Figure 76. Germany Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 77. France Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Burns and Scalds Treatment Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Burns and Scalds Treatment Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Burns and Scalds Treatment Sales Market Share by Application (2021-2026)
Figure 84. Egypt Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Burns and Scalds Treatment Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Burns and Scalds Treatment in 2026
Figure 90. Manufacturing Process Analysis of Burns and Scalds Treatment
Figure 91. Industry Chain Structure of Burns and Scalds Treatment
Figure 92. Channels of Distribution
Figure 93. Global Burns and Scalds Treatment Sales Market Forecast by Region (2027-2032)
Figure 94. Global Burns and Scalds Treatment Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Burns and Scalds Treatment Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Burns and Scalds Treatment Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Burns and Scalds Treatment Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Burns and Scalds Treatment Revenue Market Share Forecast by Application (2027-2032)